Celebrating 40-Years of World-Class Heart Research and Education
Creating a world without heart and vascular disease
We are the Minneapolis Heart Institute Foundation® (MHIF).
For 40 years, we’ve been a world-class cardiovascular research and education organization committed to making the impossible possible for our patients.
Patients are at the heart of our mission. We provide:
•Hope for patients, improving their well-being and life expectancy
•Hope for their children, siblings, parents and families
•Hope for new treatment options
•Hope for a world without heart and vascular disease
Benefits of Participating in Research
Every year, exciting breakthroughs and new discoveries stem from our research. These important findings advance medical knowledge, improving the health and lives of millions of people worldwide.
Be More Active
Potential to Unlock More Options
Make a Contribution
Find Clinical Research Trials
Read Our Latest News
Late-breaking Clinical Research Reveals Advances in Chronic Total Occlusion (CTO) Care and Outcomes Based on Data from More than 10,000 Patients Worldwide
The Minneapolis Heart Institute Foundation presented today late-breaking clinical research showcasing advanced outcomes over the last 10 years with cutting-edge treatment strategies for serious, chronic total occlusions (CTOs), the most complex, total blockages in the coronary arteries.
Minneapolis Heart Institute Foundation is proud to be a part of the first-in-the-world enrollment in the FDY- 531-302 study for patients who have had a heart attack
This study is sponsored by Faraday Pharmaceuticals, Inc. and is targeting patients seeking emergency care for a presumed heart attack. Out of 150 centers worldwide and a total cohort of 2,300 patients, MHIF was the first to enroll a patient into this study.
The Minneapolis Heart Institute Foundation team is celebrating a big accomplishment that was made possible thanks to the bravery of patients, the determination of doctors, the support of our community, and groundbreaking technology. A new heart transplant device, known as the heart-in-a-box, was recently approved by the FDA.
Join Us at Upcoming Events
Join us for our Heart 360 Concert on September 24! Look forward to an evening of extraordinary entertainment with special guest Harry Connick, Jr. at The Armory in celebration of 40 years of world-class cardiovascular research and education.
In partnership with Pie Medical Imaging®, we are offering our fifth interactive, hands-on physician-led training workshop focused on increasing the competence in CT planning for transcatheter mitral valve interventions.
Gather with women from different backgrounds, including community leaders, business owners, patients, physicians and artists. Together, we will learn more about heart and vascular disease in women in our community.